Proteasome-mediated Glucocorticoid Receptor Degradation Restricts Transcriptional Signaling by Glucocorticoids
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Ligand-dependent down-regulation of the glucocorticoid receptor (GR) has been shown to limit hormone responsiveness, but the mechanisms involved in this process are poorly understood. The glucocorticoid receptor is a phosphoprotein that upon ligand binding becomes hyperphosphorylated, and recent evidence indicates that phosphorylation status of the glucocorticoid receptor plays a prominent role in receptor protein turnover. Because phosphorylation is a key signal for ubiquitination and proteasomal catabolism of many proteins, we evaluated whether the ubiquitin-proteasomal pathway had a role in glucocorticoid receptor down-regulation and the subsequent transcriptional response to glucocorticoids. Pretreatment of COS-1 cells expressing mouse glucocorticoid receptor with the proteasome inhibitor MG-132 effectively blocks glucocorticoid receptor protein down-regulation by the glucocorticoid dexamethasone. Interestingly, both MG-132 and a second proteasome inhibitor beta-lactone significantly enhanced hormone response of transfected mouse glucocorticoid receptor toward transcriptional activation of glucocorticoid receptor-mediated reporter gene expression. The transcriptional activity of the endogenous human glucocorticoid receptor in HeLa cells was also enhanced by MG-132. Direct evidence for ubiquitination of the glucocorticoid receptor was obtained by immunoprecipitation of cellular extracts from proteasome-impaired cells. Examination of the primary sequence of mouse, human, and rat glucocorticoid receptor has identified a candidate PEST degradation motif. Mutation of Lys-426 within this PEST element both abrogated ligand-dependent down-regulation of glucocorticoid receptor protein and simultaneously enhanced glucocorticoid receptor-induced transcriptional activation of gene expression. Unlike wild type GR, proteasomal inhibition failed to enhance significantly transcriptional activity of K426A mutant GR. Together these findings suggest a major role of the ubiquitin-proteasome pathway in regulating glucocorticoid receptor protein turnover, thereby providing a mechanism to terminate glucocorticoid responses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GR is ubiquitinated at a conserved lysine residue located at position 419 (Lys-419), and this modification targets the receptor for degradation by the 26S proteasome (Fig.3B)78,79.”
From Corticosteroids (2016) · cites this paper as [79]
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541
Sapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Amino Acid Sequences Common to Rapidly Degraded Proteins: The PEST Hypothesis
Rogers, S., Wells, R., & Rechsteiner, M. (1986) · Science · doi:10.1126/science.2876518 · Cited by 2,537
STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES
Coux, O., Tanaka, K., & Goldberg, A. L. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.004101 · Cited by 2,487
PEST sequences and regulation by proteolysis
Rechsteiner, M., & Rogers, S. W. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10031-1 · Cited by 1,640
Anti-inflammatory Actions of Glucocorticoids: Molecular Mechanisms
Barnes, P. J. (1998) · Clinical Science · doi:10.1042/cs0940557 · Cited by 1,591
Proteasome inhibitors: valuable new tools for cell biologists.
Lee, D. H., & Goldberg, A. L. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01346-4 · Cited by 1,474
Degradation of CFTR by the ubiquitin-proteasome pathway
Ward, C. L., Omura, S., & Kopito, R. R. (1995) · Cell · doi:10.1016/0092-8674(95)90240-6 · Cited by 1,304
Research works printed but not linked: 11
- Sapolsky, 2000, Endocr. Rev., 21, 55
- McKay, 1999, Endocr. Rev., 20, 435
- Bellingham, 1992, Mol. Endocrinol., 6, 2090
- Oakley, 1993, Crit. Rev. Eukaryotic Gene Expr., 3, 63
- Schmidt, 1994, Receptor, 4, 229
- Burnstein, 1994, Mol. Endocrinol., 8, 1764
- Danielsen, 1989, Cancer Res., 49, 2286
- McKay, 2000, Mol. Endocrinol., 14, 1222
- Whitesell, 1996, Mol. Endocrinol., 10, 705
- Vedeckis, 1989, Cancer Res., 49, 2295
- Nawaz, 1999, Cancer Res., 59, 372
Cited by
Items 201–300 of 404
Molecular mechanisms contributing to glucocorticoid resistance in lymphoid malignancies
Scheijen, B. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.29 · Cited by 41
“In addition, proteasome-mediated degradation of the GRa protein results in increased turnover of the receptor([93]).”
BackgroundKinyamu, H. K., Collins, J. B., Grissom, S. F., Hebbar, P. B., & Archer, T. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20440 · Cited by 35
“As demonstrated previously for model genes in vitro, proteasome inhibition enhanced glucocorticoid-mediated gene expression [22,23].”
BackgroundInfluentialUbcH7 interacts with the glucocorticoid receptor and mediates receptor autoregulation
Garside, H., Waters, C. E., Berry, A., Rice, L., Ardley, H. C., White, A. E., Robinson, P. A., & Ray, D. W. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06799 · Cited by 33
“Indeed, there is evidence that the GR contains multiple ubiquitylation sites, but quantification of levels of ubiquitylation has proved difficult (Wallace & Cidlowski 2001).”
BackgroundInfluentialMechanisms behind context-dependent role of glucocorticoids in breast cancer progression
Butz, H., & Patócs, A. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10047-1 · Cited by 30
“Also, the phosphorylation of individual serine residues may potentially have effects on the subcellular localization [12, 13], as it decreases the half-life of the GR by promoting a rapid turnover [13, 82, 83] and hyperphosphorylation of GR might account for the glucocorticoid resistance that is observed during the GS…”
BackgroundDekelbab, B. H., Witchel, S. F., & DeFranco, D. B. (2007) · Steroids · doi:10.1016/j.steroids.2007.05.007 · Cited by 29
“Degradation of MHC is a major contributor to skeletal muscle proteolysis seen in sepsis [25].”
BackgroundAziz, M. H., Shen, H., & Maki, C. G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.393256 · Cited by 30
“GR is targeted for proteasomal degradation upon ligand binding/activation as part of an autoregulatory feedback loop that limits GR activity (45, 46).”
BackgroundSmall-Molecule Hormones: Molecular Mechanisms of Action
Puzianowska‐Kuźnicka, M., Pawlik-Pachucka, E., Owczarz, M., Budzińska, M., & Połosak, J. (2013) · International Journal of Endocrinology · doi:10.1155/2013/601246 · Cited by 30
“In addition, its biological efficiency depends on the rate of its turnover [77].”
BackgroundModifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer
Leehy, K. A., Anderson, T. M. R., Daniel, A. R., Lange, C. A., & Ostrander, J. H. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0322 · Cited by 30
“For example, ubiquitination at Lys-419 in a conserved PEST degradation motif targets GR for proteasomal degradation in a ligand-dependent manner, thus altering receptor halflife and transcriptional activity (Wallace & Cidlowski 2001, Deroo et al.”
BackgroundXenobiotics and the Glucocorticoid Receptor
Gulliver, L. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.02.003 · Cited by 28
Oppositional Regulation of Noxa by JNK1 and JNK2 during Apoptosis Induced by Proteasomal Inhibitors
Pietkiewicz, S., Sohn, D., Piekorz, R. P., Grether‐Beck, S., Budach, W., Sabapathy, K., & Jänicke, R. U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061438 · Cited by 28
“From these, we closely examined the role of several transcription factors including ATF3, ATF4, c-Jun, c-Myc, HIF1a, p53, and the glucocorticoid receptor (GR), as most of them were not only shown to transcriptionally regulate Noxa expression [17,27–31], and known to be involved in JNK signaling [32–37], but also becau…”
BackgroundProteolytic Targeting of Transcriptional Regulator TIP120B by a HECT Domain E3 Ligase
You, J., Wang, M., Aoki, T., Tamura, T., & Pickart, C. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212887200 · Cited by 27
Park, J., Kim, M., Na, G., Jeon, I., Kwon, Y.-K., Kim, J.-H., Youn, H., & Koo, Y. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.08.002 · Cited by 26
Regulation of Glucocorticoid Receptor Activity by a Stress Responsive Transcriptional Cofactor
Davies, L., Paraskevopoulou, E., Sadeq, M., Symeou, C., Pantelidou, C., Demonacos, C., & Krstic–Demonacos, M. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0212 · Cited by 30
Mota, R. I., Parry, T. L., Yates, C. C., Qiang, Z., Eaton, S. C., Mwiza, J.-M., Tulasi, D. Y., Schisler, J. C., Patterson, C., Zaglia, T., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.04.007 · Cited by 28
“Because GR degradation occurs in a proteasome-dependent manner 39 and the ubiquitin ligase mediating its degradation is unknown, we hypothesized that atrogin-1 might mediate this degradation.”
BackgroundShih, C.-T., Shiau, C., Chen, Y., Chen, L.-J., Chao, T.-I., Wang, C., Huang, C., Hung, M., & Chen, K. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.043 · Cited by 24
Heinrich, U., Strieth, S., Schmidtmann, I. M., Stauber, R. H., & Helling, K. (2015) · The Laryngoscope · doi:10.1002/lary.25345 · Cited by 24
Riffle, B. W., Klinefelter, G. R., Cooper, R. L., Winnik, W., Swank, A., Jayaraman, S., Suarez, J. D., Best, D. S., & Laws, S. C. (2014) · Reproductive Toxicology · doi:10.1016/j.reprotox.2014.05.008 · Cited by 24
Obinata, H., Yokomizo, T., Shimizu, T., & Izumi, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01554-7 · Cited by 24
Keenan, C. R., Lew, M. J., & Stewart, A. G. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.02.008 · Cited by 25
Yip, H. Y. K., Chee, A., Ang, C., Shin, S., Ooms, L. M., Mohammadi, Z., Phillips, W. A., Daly, R. J., Cole, T. J., Bronson, R. T., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.09.027 · Cited by 24
Suzuki, S., Okada, M., Sanomachi, T., Togashi, K., Seino, S., Satō, A., Yamamoto, M., & Kitanaka, C. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015223 · Cited by 23
“2A) (26, 27), we examined the effect of siRNA-mediated GR knockdown on dexamethasone’s CSC-inhibitory effects.”
BackgroundIntersection of nuclear receptors and the proteasome on the epigenetic landscape
Kinyamu, H. K., Jefferson, W. N., & Archer, T. (2007) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20360 · Cited by 27
“…Receptor-Regulated Transcription—Studies where proteasome activity is inhibited with drugs such as MG132 imply that proteasome activity is required for activation of transcription by some, but not all NRs [Lonard et al., 2000; Wallace and Cidlowski, 2001; Deroo et al., 2002; Dennis et al., 2005].”
BackgroundWhirledge, S., & Cidlowski, J. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00005-6 · Cited by 28
Self-citationChapter 4 Emerging Roles of the Ubiquitin Proteasome System in Nuclear Hormone Receptor Signaling
Lonard, D. M., & O’Malley, B. W. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)87004-x · Cited by 25
Pin1 promotes GR transactivation by enhancing recruitment to target genes
Poolman, T. M., Farrow, S. N., Matthews, L. C., Loudon, A. S. I., & Ray, D. W. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt624 · Cited by 23
“GR is subjected to numerous post-translational modifications, including phosphorylation (39), ubiquitination (40) and sumoylation (41), some of which have been shown to contribute to resistance states (42).”
BackgroundTreatment of pityriasis rubra pilaris type I: a systematic review
Engelmann, C., Elsner, P. U., & Miguel, D. (2019) · European Journal of Dermatology · doi:10.1684/ejd.2019.3641 · Cited by 23
Pollenz, R. S., Popat, J., & Dougherty, E. J. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.006 · Cited by 26
Kino, T. (2018) · Endocrinology · doi:10.1210/en.2017-03254 · Cited by 22
Webster, J. I., & STERNBERG, E. M. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.03.011 · Cited by 21
Glucocorticoid Resistance in Inflammatory Diseases
Chrousos, G., & Franchimont, D. (2004) · CRC Press eBooks · doi:10.1201/9780203021941-39 · Cited by 21
Lesovaya, E. A., Yemelyanov, A. Y., Игоревич, К. К., Геннадиевна, Я. М., & Budunova, I. V. (2011) · Biochemistry (Moscow) · doi:10.1134/s000629791111006x · Cited by 20
Determinants of the heightened activity of glucocorticoid receptor translational isoforms
Bender, I. K., Cao, Y., & Lu, N. Z. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1009 · Cited by 19
“The GR is degraded through the E2 ubiquitin-conjugating enzymes and/or E3 ubiquitin ligase–dependent unbiquitin-proteasome pathway (58).”
BackgroundČíkoš, Š., Babeľová, J., Špirková, A., Burkuš, J., Kovaříková, V., Šefčíková, Z., Fabián, D., & Koppel, J. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy196 · Cited by 19
Glucocorticoids and Immunity: Mechanisms of Regulation
Schoneveld, O., & Cidlowski, J. A. (2007) · Elsevier eBooks · doi:10.1016/b978-012088576-3/50005-8 · Cited by 22
Self-citationGlucocorticoids: Molecular Mechanisms of Action
Cruz‐Topete, D., & Cidlowski, J. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-77658-3_11 · Cited by 20
Self-citationNovel role for receptor dimerization in post-translational processing and turnover of the GRα
Wilkinson, L., Verhoog, N. J. D., & Louw, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-32440-z · Cited by 19
Delangre, E., Liu, J., Tolu, S., Maouche, K., Armanet, M., Cattan, P., Pommier, G., Bailbé, D., & Movassat, J. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04419-8 · Cited by 19
“Dexa-treated INS-1 832/13 cells also showed decreased GR protein level, likely reflecting an adaptive mechanism [26].”
BackgroundExpression of chimeric estrogen-glucocorticoid-receptor in the amygdala reduces anxiety
Mitra, R., & Sapolsky, R. M. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.092 · Cited by 19
Verma, G., Khan, M. F., Akhtar, W., Alam, M. M., Akhter, M., & Shaquiquzzaman, M. (2017) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2017.1356415 · Cited by 18
“Glucocorticoids, the steroid hormones produced by adrenal gland, are considered essential for life (Wallace and Cidlowski 2001).”
BackgroundOerlemans, R., Vink, J., Dijkmans, B. A. C., Assaraf, Y. G., van Miltenburg, M., van der Heijden, J., Ifergan, I., Lems, W. F., Scheper, R. J., Kaspers, G. J. L., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.060509 · Cited by 20
Yoshikawa, N., Yamamoto, K., Shimizu, N., Yamada, S., Morimoto, C., & Tanaka, H. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0264 · Cited by 18
“Because it has been shown that ligand binding affects stability of the GR (30), we examined GR protein levels after treatment with DEX or CVZ.”
Backgroundβ-Arrestin-1 inhibits glucocorticoid receptor turnover and alters glucocorticoid signaling
Petrillo, M. G., Oakley, R. H., & Cidlowski, J. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.007150 · Cited by 17
“Indeed, mutation of lysine 419 of the PEST motif (which is associated with protein ubiquitination and proteasomal degradation (70)) mimicked the actions of MG132 (24, 71, 72).”
BackgroundInfluentialSelf-citationPFO5DoDA disrupts hepatic homeostasis primarily through glucocorticoid signaling inhibition
Wang, C., Fu, H., Yang, J., Liu, L., Zhang, F., Yang, C., Li, H., Chen, J., Li, Q., Wang, X., et al. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.130831 · Cited by 17
Bag‐1M inhibits the transactivation of the glucocorticoid receptor via recruitment of corepressors
Wei, H., Baniahmad, A., Li, J., Cheng-lin, C., Gao, W., & Liu, Y. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.07.010 · Cited by 18
“receptor K496L/I497G mutant (GRmt), which is unable to interact with Bag-1M but mediates hormone response [21], were cotransfected with the reporter plasmid.”
BackgroundEmerging roles of the 26S proteasome in nuclear hormone receptor-regulated transcription
Keppler, B. R., Archer, T., & Kinyamu, H. K. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.08.005 · Cited by 20
Moore, N. L. T., Hanson, A. R., Ebrahimie, E., Hickey, T. E., & Tilley, W. D. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105548 · Cited by 17
Gupta, S., Haldar, C., & Ahmad, R. (2014) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2014.11.013 · Cited by 16
“In addition to ligand induced degradation, phosphorylation of nuclear receptors via various signal transduction pathways and sometimes binding of co-regulator also tag nuclear receptors for ubiquitin mediated proteasomal degradation [55,57,60].”
BackgroundDynamics of Corticosteroid Receptors: Lessons from Live Cell Imaging
Nishi, M. (2011) · ACTA HISTOCHEMICA ET CYTOCHEMICA · doi:10.1267/ahc.10028 · Cited by 18
“Studies where the proteasome is inhibited with drugs such as MG132 demonstrate that proteasome activity is required for activation of transcription by some steroid receptors, but not all steroid receptors [7, 8, 20, 42].”
BackgroundChen, X., Li, M., Sun, W., Bi, Y., Cai, M., Liang, H., Yu, Q.-Q., He, X., & Weng, J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.152 · Cited by 16
The Effect of Repeated Physical Exercise on Hippocampus and Brain Cortex in Stressed Rats
Filipović, D., Gavrilović, L., Dronjak, S., & Radojcic, M. B. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1397.087 · Cited by 17
Patt, M., Gysi, J., Faresse, N., Cidlowski, J. A., & Odermatt, A. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110873 · Cited by 16
“…can modulate GR activity by post-translational modifications, including phosphorylation, ubiquitination, and SUMOylation (Faus and Haendler, 2006; Garza et al., 2010; Ismaili and Garabedian, 2004; Le Drean et al., 2002; Wallace and Cidlowski, 2001).”
BackgroundSelf-citationPosttranslational Modifications of the Mineralocorticoid Receptor and Cardiovascular Aging
Gadasheva, Y., Nolze, A., & Großmann, C. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.667990 · Cited by 15
Mata‐Greenwood, E., Stewart, J. M., Steinhorn, R. H., & Pearce, W. J. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301247 · Cited by 15
“and proteasomal degradation, and this event is stimulated by GR activation.(35,37) To determine whether Dex-sensitivity”
BackgroundModulation of the Glucocorticoid Receptor Activity by Post-Translational Modifications
Liberman, A. C., Antunica-Noguerol, M., & ARZT, E. S. (2014) · Nuclear Receptor Research · doi:10.11131/2014/101086 · Cited by 18
Therapeutic targets for new therapy for corticosteroid refractory asthma
Ito, K., & Mercado, N. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903078431 · Cited by 17
“In addition, recent evidence suggests that GR phosphorylation is involved in receptor turnover and that phosphorylation can target the receptor for hormone-mediated degradation [21].”
BackgroundDisruption of microtubules leads to glucocorticoid receptor degradation in HeLa cell line
Dvořák, Z., Modrianský, M., Ulrichová, J., Maurel, P., Vilarem, M., & Pascussi, J. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.06.010 · Cited by 17
Sueyoshi, T., Petrillo, M. G., Jewell, C. M., Bortner, C. D., Perera, L., Xu, X., Aguayo, F. I., Díaz-Jiménez, D., Robinson, A. G. J., Cook, M. E., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108488 · Cited by 17
Self-citationRNA binding by the glucocorticoid receptor attenuates dexamethasone-induced gene activation
Lammer, N. C., Ashraf, H. M., Ugay, D. A., Spencer, S. L., Allen, M. A., Batey, R., & Wuttke, D. S. (2023) · Scientific Reports · doi:10.1038/s41598-023-35549-y · Cited by 14
Castro, R. B., Longui, C. A., Faria, C. D. C., Silva, T. S. E., Richeti, F., Rocha, M. N., Melo, M. R., de Pereira, W. L. C. J., Chamlian, E. G., & Rivetti, L. A. (2012) · Genetics and Molecular Research · doi:10.4238/2012.november.21.1 · Cited by 15
“, 1997) and ubiquitination (Wallace and Cidlowski, 2001), which reduce the half-life of the receptor.”
BackgroundEnhancement of ligand-dependent down-regulation of glucocorticoid receptor by lipopolysaccharide
Hirasawa, N., Yashima, K., & Ishihara, K. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.08.012 · Cited by 15
Glucocorticoids: The mode of action in bullous pemphigoid
Kubin, M. E., Hellberg, L., & Palatsi, R. (2017) · Experimental Dermatology · doi:10.1111/exd.13408 · Cited by 16
Filipović, D., Gavrilović, L., Dronjak, S., Demajo, M., & Radojčić, M. (2008) · Physiological Research · doi:10.33549/physiolres.931152 · Cited by 14
Cell Density and Serum Exposure Modify the Function of the Glucocorticoid Receptor C/EBP Complex
Yang, J., Rüdiger, J. J., Hughes, J. M., Goulet, S., Gencay, M., Borger, P., Tamm, M., & Roth, M. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0079oc · Cited by 14
“expression suggesting a self limiting control mechanism and may result in tachyphylaxis in ( 6-8 ).”
BackgroundCaderno, A., Oliva, M., Barranco, I., Astola, A., Fuentes, J., Alarcón, F. J., Mancera, J. M., & Martos-Sitcha, J. A. (2025) · Aquaculture · doi:10.1016/j.aquaculture.2025.742873 · Cited by 13
Modulation of the circadian clock by glucocorticoid receptor isoforms in the H295R cell line
Nagy, Z., Márta, A., Butz, H., Likó, I., Rácz, K., & Patócs, A. (2016) · Steroids · doi:10.1016/j.steroids.2016.10.002 · Cited by 16
Reciprocal and Autonomous Glucocorticoid and Androgen Receptor Activation in Salivary Duct Carcinoma
Mitani, Y., Lin, S.-H., Pytynia, K. B., Ferrarotto, R., & El‐Naggar, A. K. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1603 · Cited by 14
Roderick, J. E., Gallagher, K. M., Murphy, L. C., O’Connor, K. W., Tang, K., Zhang, B., Brehm, M. A., Greiner, D. L., Yu, J., Zhu, L. J., et al. (2020) · Blood · doi:10.1182/blood.2020005712 · Cited by 13
Sala, G. L., Gunnarsson, A., Edman, K., Tyrchan, C., Hogner, A., & Frolov, A. I. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00323 · Cited by 13
Glucococorticoid-Induced Death of Pancreatic Beta Cells: An Organized Chaos
Rojas, J., Chávez-Castillo, M., Chávez-Castillo, M., Cabrera, M., Cabrera, M., Bermúdez, V., & Bermúdez, V. (2015) · PubMed · doi:10.6092/1590-8577/2893 · Cited by 16
“Although quantitative regulation of GR expression is generally subject to negative feedback [32], in certain especially susceptible cells – such as leukemia cells – autoinduction of GR expression may be an important amplifier of GC-dependent apoptosis, although the mechanisms underlying this positive feedback remain u…”
BackgroundKariagina, A., Zonis, S., Afkhami, M., Romanenko, D., & Chesnokova, V. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00577.2004 · Cited by 17
“(24) by ubiquitin-dependent proteosomal degradation (32) in both the hypothalamus and the pituitary.”
BackgroundKerksick, C. M., Willoughby, D. S., Kouretas, D., & Tsatsakis, A. M. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.04.029 · Cited by 13
Proteasome inhibitor MG-132 enhances whole-body protein turnover in rat
Holeček, M., Muthný, T., Kovařík, M., & Šišpera, L. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.053 · Cited by 12
White, J. T., Rives, J., Tharp, M. E., Wrabl, J. O., Thompson, E. B., & Hilser, V. J. (2021) · Biochemistry · doi:10.1021/acs.biochem.1c00079 · Cited by 11
Blecharz, K., Burek, M., Bauersachs, J. K., Thum, T., Tsikas, D., Widder, J. D., Roewer, N., & Förster, C. Y. (2014) · Biology of the Cell · doi:10.1111/boc.201300083 · Cited by 12
“…the ligand for reasons of proteasomal degradation of the GR, as depicted in Figure 1D and Figure 2D being in accordance with data achieved by Cidlowski et al. who has shown for the first time the GR expression status being correlated with its transcriptional activity (Wallace and Cidlowski, 2001).”
BackgroundMethodInfluentialSuzuki, M., Yoshida, H., Hashizume, M., Tanaka, K., & Matsumoto, Y. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12685 · Cited by 14
Bivol, S., Owen, S., & Rose’Meyer, R. B. (2016) · Reproduction Fertility and Development · doi:10.1071/rd15356 · Cited by 14
“A reduction in GR protein levels could be the result of ligand-induced homologous downregulation of the GR, a mechanism through which cells regulate GC responsiveness (Wallace and Cidlowski 2001; Schaaf and Cidlowski 2002).”
Duma, D., & Cidlowski, J. A. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.039 · Cited by 11
Self-citationInsight into glucocorticoid receptor signalling through interactome model analysis
Bakker, E. Y., Tian, K., Mutti, L., Demonacos, C., Schwartz, J., & Krstic–Demonacos, M. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005825 · Cited by 10
“Numerous factors control GR activity, including phosphorylation status [12], targeting to protein degradation pathways [13] and interaction with cofactors [14].”
BackgroundCinarli, F., Nicolaou, P., Spontarelli, K., Dohrn, M. F., Rebelo, A. P., Koutsou, P., Georghiou, A., Artigas, P., Zuchner, S. L., Kleopa, K. A., et al. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11581-w · Cited by 10
Environmental enrichment exerts anxiolytic effects in the Indian field mouse (Mus booduga)
Varman, D. R., Marimuthu, G., & Rajan, K. E. (2012) · Applied Animal Behaviour Science · doi:10.1016/j.applanim.2011.12.003 · Cited by 11
Functional Implications of Glucocorticoid Receptor Trafficking
DeFranco, D. B. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_7 · Cited by 10
Yoon, H. K., Li, Z. J., Choi, D.-K., Sohn, K., Lim, E.-H., Lee, Y., Kim, S., Im, M., Lee, Y., Seo, Y., et al. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-1985-7 · Cited by 10
“Negative feedback regulation of GR by GCs in a proteasome-dependent manner has been well established [28].”
BackgroundRelić, B., Charlier, E., Deroyer, C., Malaise, O., Neuville, S., Desoroux, A., Gillet, P., de Seny, D., & Malaise, M. (2016) · Oncotarget · doi:10.18632/oncotarget.8042 · Cited by 9
“GR degradation is known to be auto regulated [16] and proteasome dependent [44].”
BackgroundExpression of glucocorticoid receptor (GR) and clinical significance in adrenocortical carcinoma
Wu, K., Liu, Z., Liang, J., Zhang, F., Zhang, F., Wang, Y., Lia, T., Liu, S., Zhu, Y., & Li, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.903824 · Cited by 9
“At the RNA level, several studies have found that the mRNA levels of GR are reduced by 50-80% in many different tissues when treated with GCs (26).”
BackgroundInfluentialLucki, A., Klein, E., Karry, R., & Ben‐Shachar, D. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1099-5 · Cited by 9
Kim, J., Jeon, H.-J., Baek, J.-M., Han, K., & Dahms, H.-U. (2012) · Aquaculture Research · doi:10.1111/j.1365-2109.2012.03104.x · Cited by 9
Cornejo, S., Tantisira, K. G., Raby, B. A., Weiss, S. T., & Kaplan, F. (2015) · Pediatric Research · doi:10.1038/pr.2015.148 · Cited by 9
Lü, L., Dai, Y., Du, X., She, W., Zhang, X., Wu, Q., Yuan, W., & Chen, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056323 · Cited by 8
“However, the endogenous GCs in guinea pigs produced by stress under pathological states, as well as long-term GC application, could down-regulate the expression of GR [25].”
BackgroundGao, L., Wang, J.-F., Xiang, M., Fan, Y., Zhang, Z., & Wang, K. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1656-4 · Cited by 11
“Peripheral lymphocytes, as the various target cells of glucocorticoids, play major roles in both the pathological development of ACLF and the function of glucocorticoids [32, 33].”
BackgroundMolecular Chaperone-Mediated Nuclear Protein Dynamics
Echtenkamp, F., & Freeman, B. (2014) · Current Protein and Peptide Science · doi:10.2174/1389203715666140331112230 · Cited by 9
“However, the functional effects differ as proteasome inhibition declines ER-mediated transcription but increases GR activity [45, 93].”
BackgroundKadushkin, A. G., & Tahanovich, A. D. (2017) · PULMONOLOGIYA · doi:10.18093/0869-0189-2016-26-6-736-747 · Cited by 9
Schroeder, A., van den Buuse, M., & Hill, R. (2018) · Brain Sciences · doi:10.3390/brainsci8070118 · Cited by 8
“Overstimulation of this receptor by extremely high CORT levels may have induced downregulation of GR, most likely through the ubiquitin proteasome pathway [63] to regulate transcription levels.”
BackgroundAcevedo, A., Berthel, A., DuBois, D. C., Almon, R. R., Jusko, W. J., & Androulakis, I. P. (2019) · Gene Regulation and Systems Biology · doi:10.1177/1177625019840282 · Cited by 8
The role of calpains in ligand-induced degradation of the glucocorticoid receptor
Kim, Y. S., Kim, J., Kim, Y., Lee, Y. H., Kim, J., Lee, S., Shin, S. Y., & Ko, J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.040 · Cited by 9
“Recently, it has been reported that proteasomal inhibition increases accumulation of GR and enhances GR-mediated transactivation [24].”
BackgroundInfluentialTseng, M., Huang, S., Konrad, M., Huang, J., Shaw, S. W., Tian, Y.-C., Chueh, H., Fan, W., Wu, T.-W., Ding, J.-J., et al. (2021) · Cells · doi:10.3390/cells10040782 · Cited by 7
“The ubiquitin-proteasome pathway in regulating GR protein turnover was a classic mechanism to terminate glucocorticoid responses [17].”
BackgroundBarnes, C. C., Yee, K. T., & Vetter, D. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043320 · Cited by 7
“A study on GR (and by extension, given that MR functions similarly as a DNA-binding/transcriptional factor, we presume a similar fate for MR) demonstrated that the ubiquitin-proteosome degradation pathway terminates GR signaling and that GR is hyperphosphorylated upon ligand (GC) binding, initiating the degradation pr…”
BackgroundQattan, M. Y., Bakker, E. Y., Rajendran, R., Chen, D. W.-C., Saha, V., 刘继中, Zeef, L. A. H., Schwartz, J., Mutti, L., Demonacos, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178606 · Cited by 7
Busillo, J. M., Rhen, T., & Cidlowski, J. A. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00005-6 · Cited by 11
Self-citationPurayil, H. T., & Daaka, Y. (2022) · The Prostate · doi:10.1002/pros.24324 · Cited by 7
“to untreated control cells (Figure 2B), which is supported by previous reports that prolonged exposure to GR ligand agonists promotes GR ubiquitination and degradation in the proteasome.(30) Notably, we ob-”
Bhandari, S., Kyrrestad, I., Simón-Santamaría, J., Li, R., Szafranska, K. J., Dumitriu, G., Sánchez Romano, J., Smedsrød, B., & Sørensen, K. K. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1377136 · Cited by 6
Metadata
- Authors
- Wallace, A. D., & Cidlowski, J. A.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Cidlowski, John A.
- ORCID
- Cidlowski, John A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-11
- Volume
- 276
- Issue
- 46
- Pages
- 42714-42721
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1984573021
- Cited by
- 394
- References
- 65
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 8 · 2023: 7 · 2022: 11 · 2021: 13 · 2020: 10 · 2019: 17 · 2018: 12 · 2017: 14 · 2016: 10 · 2015: 16 · 2014: 15 · 2013: 25 · 2012: 19
- FWCI
- 10.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6924 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- glucocorticoid receptor, receptor down-regulation, ubiquitin-proteasome system, proteasome inhibition, MG132, dexamethasone, receptor phosphorylation, ubiquitination, transcriptional activation, hormone responsiveness
- MeSH terms
- Animals, Cysteine Endopeptidases, Dexamethasone, Glucocorticoids, HeLa Cells, Humans, Ligands, Luciferases, Lysine, Multienzyme Complexes, Mutation, Phosphorylation, Plasmids, Precipitin Tests, Receptors, Glucocorticoid, Time Factors, Transcription, Genetic, Transfection, Blotting, Western, Signal Transduction, Chloramphenicol O-Acetyltransferase, Transcriptional Activation, Down-Regulation, Mutagenesis, Site-Directed, COS Cells, Amino Acid Motifs, Proteasome Endopeptidase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.